Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Enliven Therapeutics, Inc. (IMRA)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -130.9% | -207.3% | |
ROIC (including intangibles) | -106.2% | -98.8% | 936.7% |
ROE | -49.4% | -83.4% | -181.8% |
ROA | -45.9% | -72.4% | -138.6% |
|
Cash Conversion Cycle |
Days sales outstanding | | | 0.0 |
Days payables outstanding | | | 31.0 |
Cash conversion cycle | | | -31.0 |
|